Publications by Børre Fevang

39 publications found

Publications 2019

  1. Holmøy T, Fevang B, Olsen DB, Spigset O, Bø L (2019)
    Adverse events with fatal outcome associated with alemtuzumab treatment in multiple sclerosis
    BMC Res Notes, 12 (1), 497
    DOI 10.1186/s13104-019-4507-6, PubMed 31405369
  2. Jørgensen SF, Holm K, Macpherson ME, Storm-Larsen C, Kummen M, Fevang B, Aukrust P, Hov JR (2019)
    Selective IgA deficiency in humans is associated with reduced gut microbial diversity
    J Allergy Clin Immunol, 143 (5), 1969-1971.e11
    DOI 10.1016/j.jaci.2019.01.019, PubMed 30707969
  3. Macpherson ME, Halvorsen B, Yndestad A, Ueland T, Mollnes TE, Berge RK, Rashidi A, Otterdal K, Gregersen I, Kong XY, Holven KB, Aukrust P, Fevang B, Jørgensen SF (2019)
    Impaired HDL Function Amplifies Systemic Inflammation in Common Variable Immunodeficiency
    Sci Rep, 9 (1), 9427
    DOI 10.1038/s41598-019-45861-1, PubMed 31263122

Publications 2018

  1. Fevang B (2018)
    Open access - elefanten (eller isbjørnen) i rommet
    Tidsskr Nor Laegeforen, 138 (2)
    DOI 10.4045/tidsskr.18.0019, PubMed 29357620
  2. Fevang B (2018)
    Open access- elephant (or polar bear) in the room
    Tidsskr. Nor. Laegeforen., 138 (2), 110
  3. Fevang B, Fagerli UM, Sorte H, Aarset H, Hov H, Langmyr M, Keil TM, Bjørge E, Aukrust P, Stray-Pedersen A, Gedde-Dahl T (2018)
    Runaway Train: A Leaky Radiosensitive SCID with Skin Lesions and Multiple Lymphomas
    Case Reports Immunol, 2018, 2053716
    DOI 10.1155/2018/2053716, PubMed 29888014
  4. Fevang P, Havemann K, Fevang B, Høstmark AT (2018)
    Malaria and Malnutrition: Kwashiorkor Associated with Low Levels of Parasitaemia
    Malar Res Treat, 2018, 7153173
    DOI 10.1155/2018/7153173, PubMed 30533212
  5. Jørgensen SF, Fevang B, Aukrust P (2018)
    Autoimmunity and Inflammation in CVID: a Possible Crosstalk between Immune Activation, Gut Microbiota, and Epigenetic Modifications
    J Clin Immunol, 39 (1), 30-36
    DOI 10.1007/s10875-018-0574-z, PubMed 30465180
  6. Nordheim E, Olafsson Storrø M, Natvik AK, Birkeland Kro G, Midtvedt K, Varberg Reisaeter A, Hagness M, Fevang B, Pettersen FO (2018)
    Donor-derived strongyloidiasis after organ transplantation in Norway
    Transpl Infect Dis, 21 (1), e13008
    DOI 10.1111/tid.13008, PubMed 30295406
  7. Otterdal K, Berg A, Michelsen AE, Patel S, Tellevik MG, Haanshuus CG, Fevang B, Aukrust P, Langeland N, Ueland T (2018)
    Soluble markers of neutrophil, T-cell and monocyte activation are associated with disease severity and parasitemia in falciparum malaria
    BMC Infect Dis, 18 (1), 670
    DOI 10.1186/s12879-018-3593-8, PubMed 30563486
  8. Troseid M, Nordoy I, Fevang B, Aukrust P (2018)
    Tenders for HIV medicines are not academically justified
    Tidsskr. Nor. Laegeforen., 138 (20), 1912-1913
  9. Trøseid M, Nordøy I, Fevang B, Aukrust P (2018)
    Tendering for HIV drugs is not clinically justified
    Tidsskr Nor Laegeforen, 138 (20)
    DOI 10.4045/tidsskr.18.0808, PubMed 30539614

Publications 2017

  1. Fevang B (2017)
    Open access - elefanten (eller isbjørnen) i rommet
    Tidsskr Nor Laegeforen, 137 (23-24)
    DOI 10.4045/tidsskr.17.1010, PubMed 29231632
  2. Fevang B (2017)
    Open access- elephant (or polar bear) in the room
    Tidsskr. Nor. Laegeforen., 137 (23-24), 1860
  3. Holm KL, Syljuåsen RG, Hasvold G, Alsøe L, Nilsen H, Ivanauskiene K, Collas P, Shaposhnikov S, Collins A, Indrevær RL, Aukrust P, Fevang B, Blomhoff HK (2017)
    TLR9 stimulation of B-cells induces transcription of p53 and prevents spontaneous and irradiation-induced cell death independent of DNA damage responses. Implications for Common variable immunodeficiency
    PLoS One, 12 (10), e0185708
    DOI 10.1371/journal.pone.0185708, PubMed 28973009
  4. Jørgensen SF, Reims HM, Aukrust P, Lundin KE, Fevang B (2017)
    CVID and Celiac Disease
    Am J Gastroenterol, 112 (2), 393
    DOI 10.1038/ajg.2016.551, PubMed 28154406
  5. Stuchlý J, Kanderová V, Vlková M, Heřmanová I, Slámová L, Pelák O, Taraldsrud E, Jílek D, Králíc Ková P, Fevang B, Trková M, Hrušák O, Froňková E, Šedivá A, Litzman J, Kalina T (2017)
    Common Variable Immunodeficiency patients with a phenotypic profile of immunosenescence present with thrombocytopenia
    Sci Rep, 7, 39710
    DOI 10.1038/srep39710, PubMed 28054583
  6. Stuchlý J, Kanderová V, Vlková M, Heřmanová I, Slámová L, Pelák O, Taraldsrud E, Jílek D, Králíčková P, Fevang B, Trková M, Hrušák O, Froňková E, Šedivá A, Litzman J, Kalina T (2017)
    Erratum: Common Variable Immunodeficiency patients with a phenotypic profile of immunosenescence present with thrombocytopenia
    Sci Rep, 7, 42569
    DOI 10.1038/srep42569, PubMed 28240280
  7. Taraldsrud E, Fevang B, Jørgensen SF, Moltu K, Hilden V, Taskén K, Aukrust P, Myklebust JH, Olweus J (2017)
    Defective IL-4 signaling in T cells defines severe common variable immunodeficiency
    J Autoimmun, 81, 110-119
    DOI 10.1016/j.jaut.2017.04.004, PubMed 28476239
  8. Vikum D, Nordøy I, Torp Andersen C, Fevang B, Line PD, Kolrud FK, Aukrust P, Buanes T (2017)
    A Young, Immunocompetent Woman with Small Bowel and Hepatic Mucormycosis Successfully Treated with Aggressive Surgical Debridements and Antifungal Therapy
    Case Rep Infect Dis, 2017, 4173246
    DOI 10.1155/2017/4173246, PubMed 29435377

Publications 2016

  1. Falkenberg-Jensen B, Aaløkken TM, Fevang B (2016)
    [Atypical mycobacteria and Lady Windermere]
    Tidsskr Nor Laegeforen, 136 (14-15), 1227
    DOI 10.4045/tidsskr.16.0235, PubMed 27554564
  2. Jørgensen SF, Macpherson ME, Bjøro K, Karlsen TH, Reims HM, Grzyb K, Fosby B, Fevang B, Aukrust P, Nordøy I (2016)
    Liver transplantation in patients with primary antibody deficiency
    J Allergy Clin Immunol, 139 (5), 1708-1710.e2
    DOI 10.1016/j.jaci.2016.10.025, PubMed 27931972
  3. Jørgensen SF, Reims HM, Frydenlund D, Holm K, Paulsen V, Michelsen AE, Jørgensen KK, Osnes LT, Bratlie J, Eide TJ, Dahl CP, Holter E, Tronstad RR, Hanevik K, Brattbakk HR, Kaveh F, Fiskerstrand T, Kran AB, Ueland T, Karlsen TH, Aukrust P, Lundin KE, Fevang B (2016)
    A Cross-Sectional Study of the Prevalence of Gastrointestinal Symptoms and Pathology in Patients With Common Variable Immunodeficiency
    Am J Gastroenterol, 111 (10), 1467-1475
    DOI 10.1038/ajg.2016.329, PubMed 27527747
  4. Sorte HS, Osnes LT, Fevang B, Aukrust P, Erichsen HC, Backe PH, Abrahamsen TG, Kittang OB, Øverland T, Jhangiani SN, Muzny DM, Vigeland MD, Samarakoon P, Gambin T, Akdemir ZH, Gibbs RA, Rødningen OK, Lyle R, Lupski JR, Stray-Pedersen A (2016)
    A potential founder variant in CARMIL2/RLTPR in three Norwegian families with warts, molluscum contagiosum, and T-cell dysfunction
    Mol Genet Genomic Med, 4 (6), 604-616
    DOI 10.1002/mgg3.237, PubMed 27896283
  5. Stray-Pedersen A, Sorte HS, Samarakoon P, Gambin T, Chinn IK, Coban Akdemir ZH, Erichsen HC, Forbes LR, Gu S, Yuan B, Jhangiani SN, Muzny DM, Rødningen OK, Sheng Y, Nicholas SK, Noroski LM, Seeborg FO, Davis CM, Canter DL, Mace EM, Vece TJ, Allen CE, Abhyankar HA, Boone PM, Beck CR et al. (2016)
    Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders
    J Allergy Clin Immunol, 139 (1), 232-245
    DOI 10.1016/j.jaci.2016.05.042, PubMed 27577878
  6. Taraldsrud E, Aukrust P, Jørgensen S, Lingjærde OC, Olweus J, Myklebust JH, Fevang B (2016)
    Patterns of constitutively phosphorylated kinases in B cells are associated with disease severity in common variable immunodeficiency
    Clin Immunol, 175, 69-74
    DOI 10.1016/j.clim.2016.11.014, PubMed 27919819

Publications 2015

  1. Indrevær RL, Moskaug JØ, Paur I, Bøhn SK, Jørgensen SF, Blomhoff R, Aukrust P, Fevang B, Blomhoff HK (2015)
    IRF4 Is a Critical Gene in Retinoic Acid-Mediated Plasma Cell Formation and Is Deregulated in Common Variable Immunodeficiency-Derived B Cells
    J Immunol, 195 (6), 2601-11
    DOI 10.4049/jimmunol.1500250, PubMed 26276871
  2. Li J, Jørgensen SF, Maggadottir SM, Bakay M, Warnatz K, Glessner J, Pandey R, Salzer U, Schmidt RE, Perez E, Resnick E, Goldacker S, Buchta M, Witte T, Padyukov L, Videm V, Folseraas T, Atschekzei F, Elder JT, Nair RP, Winkelmann J, Gieger C, Nöthen MM, Büning C, Brand S et al. (2015)
    Association of CLEC16A with human common variable immunodeficiency disorder and role in murine B cells
    Nat Commun, 6, 6804
    DOI 10.1038/ncomms7804, PubMed 25891430

Publications 2013

  1. Gregersen S, Holm AM, Fevang B, Ueland T, Sikkeland LI, Aaløkken TM, Mynarek G, Kongerud J, Aukrust P, Johansen B, Frøland SS (2013)
    Lung disease, T-cells and inflammation in common variable immunodeficiency disorders
    Scand J Clin Lab Invest, 73 (6), 514-22
    DOI 10.3109/00365513.2013.819523, PubMed 23957371
  2. Indrevær RL, Holm KL, Aukrust P, Osnes LT, Naderi EH, Fevang B, Blomhoff HK (2013)
    Retinoic acid improves defective TLR9/RP105-induced immune responses in common variable immunodeficiency-derived B cells
    J Immunol, 191 (7), 3624-33
    DOI 10.4049/jimmunol.1300213, PubMed 24006462

Publications 2012

  1. Smedbakken LM, Halvorsen B, Daissormont I, Ranheim T, Michelsen AE, Skjelland M, Sagen EL, Folkersen L, Krohg-Sørensen K, Russell D, Holm S, Ueland T, Fevang B, Hedin U, Yndestad A, Gullestad L, Hansson GK, Biessen EA, Aukrust P (2012)
    Increased levels of the homeostatic chemokine CXCL13 in human atherosclerosis - Potential role in plaque stabilization
    Atherosclerosis, 224 (1), 266-73
    DOI 10.1016/j.atherosclerosis.2012.06.071, PubMed 22840692

Publications 2010

  1. Gregersen S, Aaløkken TM, Mynarek G, Fevang B, Holm AM, Ueland T, Aukrust P, Kongerud J, Johansen B, Frøland SS (2010)
    Development of pulmonary abnormalities in patients with common variable immunodeficiency: associations with clinical and immunologic factors
    Ann Allergy Asthma Immunol, 104 (6), 503-10
    DOI 10.1016/j.anai.2010.04.015, PubMed 20568383

Publications 2009

  1. Damås JK, Landrø L, Fevang B, Heggelund L, Frøland SS, Aukrust P (2009)
    Enhanced levels of the CCR7 ligands CCL19 and CCL21 in HIV infection: correlation with viral load, disease progression and response to highly active antiretroviral therapy
    AIDS, 23 (1), 135-8
    DOI 10.1097/QAD.0b013e32831cf595, PubMed 19050397
  2. Fevang B, Eugen-Olsen J, Yndestad A, Brosstad F, Beiske K, Aukrust P, Frøland SS (2009)
    Enhanced levels of urokinase plasminogen activator and its soluble receptor in common variable immunodeficiency
    Clin Immunol, 131 (3), 438-46
    DOI 10.1016/j.clim.2009.01.007, PubMed 19232508

Publications 2008

  1. Dahl CP, Gullestad L, Fevang B, Holm AM, Landrø L, Vinge LE, Fiane AE, Sandberg WJ, Otterdal K, Frøland SS, Damås JK, Halvorsen B, Aukrust P, Øie E, Yndestad A (2008)
    Increased expression of LIGHT/TNFSF14 and its receptors in experimental and clinical heart failure
    Eur J Heart Fail, 10 (4), 352-9
    DOI 10.1016/j.ejheart.2008.02.010, PubMed 18353719
  2. Fevang B, Yndestad A, Damås JK, Bjerkeli V, Ueland T, Holm AM, Beiske K, Aukrust P, Frøland SS (2008)
    Chemokines and common variable immunodeficiency; possible contribution of the fractalkine system (CX3CL1/CX3CR1) to chronic inflammation
    Clin Immunol, 130 (2), 151-61
    DOI 10.1016/j.clim.2008.09.002, PubMed 18938112
  3. Smith C, Halvorsen B, Otterdal K, Waehre T, Yndestad A, Fevang B, Sandberg WJ, Breland UM, Frøland SS, Oie E, Gullestad L, Damås JK, Aukrust P (2008)
    High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins
    Cardiovasc Res, 79 (1), 195-203
    DOI 10.1093/cvr/cvn071, PubMed 18339644

Publications 2007

  1. Bjerkeli V, Damås JK, Fevang B, Holter JC, Aukrust P, Frøland SS (2007)
    Increased expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in Wegener's granulomatosis--possible role in vascular inflammation
    Rheumatology (Oxford), 46 (9), 1422-7
    DOI 10.1093/rheumatology/kem168, PubMed 17616549

Publications 2006

  1. Damås JK, Smith C, Øie E, Fevang B, Halvorsen B, Waehre T, Boullier A, Breland U, Yndestad A, Ovchinnikova O, Robertson AK, Sandberg WJ, Kjekshus J, Taskén K, Frøland SS, Gullestad L, Hansson GK, Quehenberger O, Aukrust P (2006)
    Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilization
    Arterioscler Thromb Vasc Biol, 27 (3), 614-20
    DOI 10.1161/01.ATV.0000255581.38523.7c, PubMed 17170367

 
Page visits: 2338